(Q28251373)
Statements
AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer (English)
0 references
15 May 2005
0 references
65
0 references
10
0 references
4389-400
0 references